Search
for

    Sort by

    Research 301–330 of 1000+

    1. Efficacy and Safety of Methotrexate Combined with Low- to Moderate-Dose Corticosteroids for Severe Alopecia Areata Dermatology · 2016 · 28 citations
    2. Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature International Journal of Women's Health · 2014 · 16 citations
    3. ALOPECIA UNIVERSALIS TREATED WITH ORAL CYCLOSPORINE A AND PREDNISOLONE: IMMUNOLOGIC STUDIES International Journal of Dermatology · 1992 · 26 citations
    4. Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study Journal of The American Academy of Dermatology · 2021 · 66 citations
    5. Safety of oral bicalutamide in female pattern hair loss: A retrospective review of 316 patients Journal of The American Academy of Dermatology · 2020 · 16 citations
    6. Acute and 30-day oral toxicity studies of a novel coccidiostat – ethanamizuril Toxicology research · 2019 · 13 citations
    7. A phase I study of MK-5108, an oral aurora A kinase inhibitor, in both monotherapy and in combination with docetaxel in patients with advanced solid tumors. Journal of Clinical Oncology · 2010 · 12 citations
    8. First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors Journal of clinical oncology · 2011 · 505 citations
    9. Cosmetic Treatment Using Botulinum Toxin in the Oral and Maxillofacial Area: A Narrative Review of Esthetic Techniques Toxins · 2023 · 52 citations
    10. Urticaria pigmentosa-like skin disease in a domestic shorthair cat Journal of feline medicine and surgery open reports · 2019 · 6 citations
    11. Disposition and pharmacokinetics of [14C]finasteride after oral administration in humans. PubMed · 1992 · 17 citations
    12. First-in-human phase 1 study of ETC-159 an oral PORCN inhbitor in patients with advanced solid tumours. Journal of Clinical Oncology · 2017 · 33 citations
    13. Systemic subchronic toxicity and comparison of four selenium nutritional supplements by 90-day oral exposure in Sprague-Dawley rats Food and chemical toxicology · 2023
    14. Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study 2026
    15. Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study 2026
    16. USO DO MINOXIDIL PARA TRATAMENTO DE ALOPECIA ANDROGENÉTICA 2024
    17. Oral minoxidil 7.5 mg for hair loss increases heart rate with no change in blood pressure in 24 h Holter and 24 h ambulatory blood pressure monitoring 2024
    18. Pericardial Disorders Occurring during Open Label Study of 3747 Patients Treated with Systemic Minoxidil International Journal of Trichology · 2025
    19. Cyproterone acetate as initial treatment and maintenance therapy for hirsutism European journal of endocrinology · 1985 · 18 citations
    20. Systemic Minoxidil Accidental Exposure in a Paediatric Population: A Case Series Study of Cutaneous and Systemic Side Effects Journal of Clinical Medicine · 2021 · 15 citations
    21. Referee report. For: Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study [version 1; referees: 2 approved] Faculty of 1000 Research Ltd · 2017
    22. Minoxidil oral en dosis bajas en alopecia frontal fibrosante: serie de 122 pacientes Actas Dermo-Sifiliográficas · 2024
    23. Literature Review: Naltrexone: New Use for an Old Drug Hair transplant forum international · 2018
    24. Hair Growth on Nude Mice Due to Cyclosporin A The Journal of Dermatology · 1991 · 25 citations
    25. 74924 Oral Minoxidil for Pediatric and Adolescent Hair Loss: A Cross-Sectional Survey of Satisfaction and Perceived Benefit Journal of the American Academy of Dermatology · 2026
    26. Position of systemic therapy in the treatment of lichen pigmentosus Our Dermatology Online · 2025
    27. Hyperpigmentation, severe alopecia, and six days of instability in a case of severe methotrexate hypersensitivity reaction Daru · 2021 · 5 citations
    28. Referee report. For: Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study [version 1; referees: 1 approved] Faculty of 1000 Research Ltd · 2017
    29. The use of minoxidil in diseases associated with hair loss Przegla̧d dermatologiczny · 2022
    30. Randomized controlled trial to compare the efficacy of oral minoxidil 1.25 mg versus 2.5 mg versus topical 5% minoxidil in androgenetic alopecia Dermatologica Sinica · 2026